Cinctive Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$894K Buy
+31,828
New +$847K 0.06% 265
2025
Q4
Sell
-459,455
Closed -$11.7M 493
2025
Q3
$11.7M Buy
459,455
+309,009
+205% +$7.63M 0.56% 47
2025
Q2
$3.65M Sell
150,446
-26,292
-15% -$613K 0.19% 157
2025
Q1
$4.48M Sell
176,738
-4,564
-3% -$119K 0.34% 95
2024
Q4
$4.81M Buy
181,302
+12,060
+7% +$327K 0.24% 135
2024
Q3
$4.9M Sell
169,242
-374,035
-69% -$10.9M 0.27% 123
2024
Q2
$15.2M Buy
543,277
+405,811
+295% +$11.2M 0.72% 28
2024
Q1
$3.81M Buy
137,466
+123,638
+894% +$3.43M 0.18% 158
2023
Q4
$398K Buy
+13,828
New +$418K 0.03% 323
2022
Q2
Sell
-82,466
Closed -$4.27M 606
2022
Q1
$4.27M Sell
82,466
-14,474
-15% -$751K 0.16% 212
2021
Q4
$5.72M Buy
+96,940
New +$4.8M 0.25% 128

Other funds holding PFE

Cinctive Capital Management's PFE Position: Q1 2026 in Review

Cinctive Capital Management opened a new position in Pfizer (PFE) in Q1 2026: 31,828 shares worth $894K. The stake represents 0.06% of the portfolio and ranks #265 among its holdings. This is a return to the name: Cinctive Capital Management previously reported a position in PFE as recently as Q3 2025.

Cinctive Capital Management first reported a position in PFE in Q4 2021 and has held it in 11 quarters since. The position peaked at $15.2M in Q2 2024. 2,933 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Cinctive Capital Management held 31,828 shares of Pfizer worth $894K as of Q1 2026.
  • Pfizer was a new Cinctive Capital Management position in Q1 2026.
  • Pfizer made up 0.06% of Cinctive Capital Management's portfolio in Q1 2026, its #265 holding.
  • Cinctive Capital Management first reported a position in Pfizer in Q4 2021 and has held it in 11 quarters since.
  • Cinctive Capital Management's Pfizer position peaked at $15.2M in Q2 2024.
  • 2,933 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.